From €995EUR$1,073USD£856GBP
- Report
- September 2024
- 25 Pages
Hungary
From €995EUR$1,073USD£856GBP
- Report
- September 2024
- 23 Pages
Greece
From €995EUR$1,073USD£856GBP
From €995EUR$1,073USD£856GBP
- Report
- September 2024
- 101 Pages
Chile
From €2675EUR$2,884USD£2,302GBP
- Report
- September 2024
- 24 Pages
China
From €995EUR$1,073USD£856GBP
- Report
- September 2024
- 24 Pages
Argentina
From €995EUR$1,073USD£856GBP
- Report
- September 2024
- 24 Pages
Chile
From €995EUR$1,073USD£856GBP
- Report
- September 2024
- 26 Pages
France
From €995EUR$1,073USD£856GBP
- Report
- September 2021
- 26 Pages
Russia
From €825EUR$890USD£710GBP
- Report
- August 2024
- 104 Pages
China
From €1788EUR$1,800USD£1,487GBP
- Report
- July 2024
- 280 Pages
Global
From €2638EUR$2,655USD£2,193GBP
The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more